Truist on Insmed (INSM): 'We See a Favorable Risk/Reward Profile'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| INSMED (NASDAQ: INSM) | Delayed: 109.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $109.31 | 52 Week High | $19.30 | |||
| Open | $109.31 | 52 Week Low | $9.02 | |||
| Day High | $109.31 | P/E | N/A | |||
| Day Low | $109.31 | EPS | $-1.69 | |||
| Volume | 1,826 | |||||
